Literature DB >> 24894104

Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy.

Imma Armadans-Tremolosa1, Albert Selva-O'Callaghan, Bienvenido Visauta-Vinacua, Georgina Guilera, Iago Pinal-Fernández, Miquel Vilardell-Tarrés.   

Abstract

Health-related quality of life (HRQoL) and well-being are concepts that attempt to objectively capture a person's subjective perceptions of vitality and energy. Our objectives were to determine HRQoL and well-being in adult patients diagnosed with inflammatory myopathy who attended at our outpatient clinic and to investigate clinical and biological correlations with these concepts. Sixty-two patients (52 women), with a mean age of 50.7 years, were evaluated in this cross-sectional study-47 with dermatomyositis and 15 with polymyositis. Disease damage and activity were assessed with the International Myositis Assessment and Clinical Studies-validated instruments. Manual muscle testing was used to evaluate muscle strength. Quality of life was evaluated with the WHO instrument (WHO Quality of Life Measure (WHOQOL-BREF)), adapted for use in the Spanish population, and well-being with the WHO-Five Well-Being Index (WHO-5). t tests were conducted to examine differences in HRQoL and well-being outcomes in relation to several disease- and patient-related variables. Correlation analyses were performed with the Pearson correlation coefficient. None of the clinical or biological variables analyzed was significantly associated with a poorer HRQoL or well-being. No differences in HRQoL or WHO-5 well-being score were found between the two myositis subgroups (dermatomyositis vs. polymyositis). Disease activity and muscle weakness were negatively associated with the physical and environmental domains of the HRQoL, respectively (p < 0.002), but not with well-being. Disease duration did not have a significant impact on HRQoL or well-being. In adult patients with myositis, disease activity and muscle weakness are associated with poorer HRQoL in the physical health and environmental domains, respectively.

Entities:  

Mesh:

Year:  2014        PMID: 24894104     DOI: 10.1007/s10067-014-2685-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  The WHO quality of life (WHOQOL) questionnaire: Spanish development and validation studies.

Authors:  Ramona Lucas-Carrasco
Journal:  Qual Life Res       Date:  2011-05-25       Impact factor: 4.147

5.  A comparative study of outcome in myositis and other musculoskeletal disorders assessed using the Nottingham health profile.

Authors:  Y L Chung; H L Mitchell; D A Houssien; H Al-Mahrouki; A J Carr; D L Scott
Journal:  Clin Exp Rheumatol       Date:  2001 Jul-Aug       Impact factor: 4.473

Review 6.  A systematic review of quality of life in adults with muscle disease.

Authors:  Christopher D Graham; Michael R Rose; Elizabeth A Grunfeld; Simon D Kyle; John Weinman
Journal:  J Neurol       Date:  2011-05-20       Impact factor: 4.849

Review 7.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

8.  Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

Authors:  A Ponyi; G Borgulya; T Constantin; A Váncsa; L Gergely; K Dankó
Journal:  Rheumatology (Oxford)       Date:  2004-09-20       Impact factor: 7.580

9.  Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease.

Authors:  Monika R Asnani; Garth E Lipps; Marvin E Reid
Journal:  Health Qual Life Outcomes       Date:  2009-08-10       Impact factor: 3.186

Review 10.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

View more
  8 in total

1.  Quality of life correlates with muscle strength in patients with dermato- or polymyositis.

Authors:  Karina B Poulsen; Helene Alexanderson; Christine Dalgård; Søren Jacobsen; Louise Weile; Louise P Diederichsen
Journal:  Clin Rheumatol       Date:  2017-06-06       Impact factor: 2.980

2.  Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies.

Authors:  Michal Feldon; Payam Noroozi Farhadi; Hermine I Brunner; Lukasz Itert; Bob Goldberg; Abdullah Faiq; Jesse Wilkerson; Kathryn M Rose; Lisa G Rider; Frederick W Miller; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

Review 3.  The health-related quality of life, mental health and mental illnesses of patients with inclusion body myositis (IBM): results of a mixed methods systematic review.

Authors:  Katja C Senn; Laura Gumbert; Simone Thiele; Sabine Krause; Maggie C Walter; Klaus H Nagels
Journal:  Orphanet J Rare Dis       Date:  2022-06-16       Impact factor: 4.303

4.  213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015.

Authors:  Olivier Benveniste; Lisa G Rider
Journal:  Neuromuscul Disord       Date:  2016-05-27       Impact factor: 4.296

5.  Dysphonia and dysphagia as early manifestations of autoimmune inflammatory myopathy.

Authors:  Samuel F Weinreb; Krzysztof Piersiala; Alexander T Hillel; Lee M Akst; Simon R Best
Journal:  Am J Otolaryngol       Date:  2020-10-03       Impact factor: 1.808

6.  Functioning in adult patients with idiopathic inflammatory myopathy: Exploring the role of environmental factors using focus groups.

Authors:  I Armadans-Tremolosa; G Guilera; M Las Heras; A Castrechini; A Selva-O'Callaghan
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

7.  Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index.

Authors:  Peter B Chansky; Jeannette M Olazagasti; Rui Feng; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-10-21       Impact factor: 15.487

Review 8.  Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review.

Authors:  Valérie Leclair; Malin Regardt; Sophie Wojcik; Marie Hudson
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.